Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.2900 (3.06%) ($0.2900 - $0.2900) on Fri. May. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.69% (three month average) | RSI | 45 | Latest Price | $0.2900(3.06%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IWN(98%) IWD(97%) IBB(94%) XLRE(94%) ACES(90%) | Factors Impacting ANPC price | ANPC will decline at least -5.345% in a week (0% probabilities). SHY(-46%) UUP(-29%) VCSH(6%) BND(9%) BNDX(14%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.345% (StdDev 10.69%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-27.45(-9565.52%) | Resistance Level | $0.34 | 5 Day Moving Average | $0.29(0%) | 10 Day Moving Average | $0.31(-6.45%) | 20 Day Moving Average | $0.34(-14.71%) | To recent high | -65.9% | To recent low | 7.4% | Market Cap | $2m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |